A New Indicator to Assess Stenosis Severity

Fractional Myocardial Mass to Assess Stenosis Severity

This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of stenosis physiological severity.

 

Researchers used CT angiography to study this new concept of myocardial mass subtended by a specific vessel, which could reduce anatomical-physiological mismatch.

 

The study included 463 patients with 724 lesions evaluated by multislice coronary computed tomography angiography and invasive coronary angiography with fractional flow reserve measurement (FFR).

 

Fractional myocardial mass was assessed based on arterial tree length and myocardial mass by CT.

 

FFR <0.80 was considered a functionally significant lesion and it was found in 39% of observed vessels. Fractional myocardial mass decreased consistently according to vessel caliber, which is obvious.

 

FFR <0.80 increased in direct proportion to fractional myocardial mass and inversely to angiographic minimal luminal diameter (p < 0.001).

 

Fractional myocardial mass and minimal luminal diameter showed good correlation with FFR (r=0.61) and resulted superior to stenosis diameter to predict FFR <0.80.

 

Optimal cutoff value for fractional myocardial mass/minimal luminal diameter was 29 g/mm with 75% sensitivity,   77% specificity and 77% diagnostic accuracy.

 

This relation could add information to the classical stenosis diameter to predict FFR<0.80.

 

 

Conclusion

The relation fractional myocardial mass / minimal luminal diameter could help discriminate functional compromise of vessels more accurately than anatomical stenosis. The concept of fractional myocardial mass could explain the discrepancy between anatomy and physiology.

 

Original Title: Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery.

Reference: Hyung Yoon Kim et al. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60.

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...